Journal of the National Cancer Institute Advance Access originally published online on January 13, 2009
JNCI Journal of the National Cancer Institute 2009 101(2):124; doi:10.1093/jnci/djn443
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press 2009.
CORRESPONDENCE |
Re: Prostatectomy vs Watchful Waiting in Localized Prostate Cancer: The Scandinavian Prostate Cancer Group-4 Randomized Trial
Affiliations of authors: Department of Therapeutic Radiology, Yale University, New Haven, CT (RJS); Department of Radiation Oncology, Southern California Permanente Medical Group, Los Angeles, CA (ARK)
Correspondence to: Robert J. Schulz, PhD, Department of Therapeutic Radiology, Yale University, New Haven, CT 06520 (e-mail: schulz@pshift.com).
| The first 10% of the full text of this article appears below. |
In their fourth report on a randomized trial of prostatectomy vs watchful waiting, the Scandinavian Prostate Cancer Group Study (1) provided a comprehensive account of the patients baseline clinical characteristics, factors influencing overall and cause-specific mortality and distant metastases, and associations of mortality with extracapsular spread and Gleason score. This report described a most remarkable clinical study that should be widely